login

Early manifest glaucoma trial

OphthalmologyPublished 1 November 1999
M. Cristina Leske, Anders Heijl, Leslie Hyman, Bo Bengtsson
Citations556
SJR quartileQ1
SJR score4.55
SNIP4.23

TL;DR

The EMGT is the first large randomized, clinical trial to evaluate the role of immediate pressure reduction, as compared to no initial reduction, in patients with early glaucoma and normal or moderately elevated IOP, and its results will have implications for the clinical management of glau coma.

Abstract

The Early Manifest Glaucoma Trial is the first large randomized, clinical trial to evaluate the role of immediate pressure reduction, as compared to no initial reduction, in patients with early glaucoma and normal or moderately elevated IOP. Its results will have implications for: (1) the clinical management of glaucoma; (2) understanding the role of IOP and the natural history of glaucoma; and (3) evaluating the rationale for glaucoma screening.

Keywords

Medicine